Found: 16
Select item for more details and to access through your institution.
Smoking influences the outcomes of patients receiving tyrosine kinase inhibitors for chronic myeloid leukemia in the chronic phase: A retrospective analysis.
- Published in:
- 2019
- By:
- Publication type:
- clinical trial
Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.
- Published in:
- Internal Medicine, 2023, v. 62, n. 22, p. 3299, doi. 10.2169/internalmedicine.1611-23
- By:
- Publication type:
- Article
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 11, p. 2081, doi. 10.1007/s00277-018-3412-8
- By:
- Publication type:
- Article
A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4.
- Published in:
- Oncogene, 2002, v. 21, n. 32, p. 4983, doi. 10.1038/sj.onc.1205628
- By:
- Publication type:
- Article
The EUTOS long‐term survival score predicts disease‐specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice‐based cohort.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8931, doi. 10.1002/cam4.3516
- By:
- Publication type:
- Article
Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR<sup>4.5</sup>): The phase 2, multicenter N‐Road study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 11, p. 3742, doi. 10.1002/cam4.3034
- By:
- Publication type:
- Article
Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders.
- Published in:
- European Journal of Haematology, 2005, v. 74, n. 5, p. 424, doi. 10.1111/j.1600-0609.2005.00417.x
- By:
- Publication type:
- Article
Molecular Analysis of Oncogenes, ras Family Genes ( N-ras, K-ras, H-ras), myc Family Genes ( c-myc, N-myc) and mdm2 in Natural Killer Cell Neoplasms.
- Published in:
- Cancer Science, 2002, v. 93, n. 11, p. 1270, doi. 10.1111/j.1349-7006.2002.tb01234.x
- By:
- Publication type:
- Article
CD4<sup>+</sup>CD8<sup>−</sup> T cell large granular lymphocytic leukaemia with central nervous system involvement.
- Published in:
- Histopathology, 2012, v. 60, n. 3, p. 519, doi. 10.1111/j.1365-2559.2011.04065.x
- By:
- Publication type:
- Article
C-kit-positive acute myelogenous leukemia effectively treated with imatinib: A case report and review of the literature.
- Published in:
- Geriatrics & Gerontology International, 2012, v. 12, n. 4, p. 762, doi. 10.1111/j.1447-0594.2012.00874.x
- By:
- Publication type:
- Article
Pure red cell aplasia associated with expansion of CD3[sup +] CD8[sup +] granular lymphocytes expressing cytotoxicity against HLA-E[sup +] cells.
- Published in:
- British Journal of Haematology, 2003, v. 123, n. 1, p. 147, doi. 10.1046/j.1365-2141.2003.04553.x
- By:
- Publication type:
- Article
CD56-positive adult T-cell leukemia/lymphoma: a case report and a review of the literature.
- Published in:
- Medical Molecular Morphology, 2015, v. 48, n. 1, p. 54, doi. 10.1007/s00795-014-0072-1
- By:
- Publication type:
- Article
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response.
- Published in:
- NPJ Systems Biology & Applications, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41540-022-00248-3
- By:
- Publication type:
- Article
Comparison of the clinical outcomes of nilotinib and dasatinib therapies in newly diagnosed patients in the chronic phase of chronic myeloid leukemia: a retrospective analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Potential role for second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis.
- Published in:
- Oncology Reports, 2019, v. 42, n. 6, p. 2836, doi. 10.3892/or.2019.7339
- By:
- Publication type:
- Article